Scintigraphic techniques in primary hyperparathyroidism: From pre-operative localisation to intra-operative imaging

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 34, Issue 6, 2007, Pages 926-933

  Rubello, Domenico ^a   Gross, Milton D ^b   Mariani, Giuliano ^c   Al Nahhas, Adil ^d  

^a S MARIA DELLA MISERICORDIA HOSPITAL   (Italy)

^b VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF PISA   (Italy)

^d HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

99mTc MIBI; Gamma probe; Minimally invasive parathyroidectomy; Primary hyperparathyroidism; Radio guided surgery

Indexed keywords

CARBON 11; CHLORIDE; FLUORODEOXYGLUCOSE F 18; IODINATED CONTRAST MEDIUM; IODINE; IODINE 123; METHIONINE C 11; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PERTECHNETIC ACID TC 99M; POTASSIUM PERCHLORATE; SELENOMETHIONINE SE 75; TECHNETIUM 99M; TETROFOSMIN TC 99M; THALLIUM 201;

ACCURACY; ANATOMY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DRUG HALF LIFE; HUMAN; IMAGING; INTRAOPERATIVE PERIOD; LOW DRUG DOSE; MINIMALLY INVASIVE SURGERY; NECK; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIMAL DRUG DOSE; PARATHYROID ADENOMA; PARATHYROIDECTOMY; PHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; PRIMARY HYPERPARATHYROIDISM; REVIEW; SCINTIGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUMOR LOCALIZATION;

ADENOMA; DIFFUSION; HUMANS; HYPERPARATHYROIDISM, PRIMARY; IMAGE PROCESSING, COMPUTER-ASSISTED; NECK; PARATHYROID GLANDS; PARATHYROID NEOPLASMS; PARATHYROIDECTOMY; RADIONUCLIDE IMAGING; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 34248997492     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-007-0388-3     Document Type: Review

References (71)

1. Heath H 3rd, Hodgson SF, Kennedy MA. Primary hyperparathyroidism. Incidence, morbidity, and potential economic impact in a community. N Engl J Med 1980;302:189-93.
2. Kaplan EL, Yashiro T, Salti G. Primary hyperparathyroidism in the 1990s. Choice of surgical procedures for this disease. Ann Surg 1992;215:301-17.
3. Sofferman RA, Nathan MH, Fairbank JT, Foster RS Jr, Krag DN. Preoperative technetium 99m sestamibi imaging. Paving the way to minimal-access parathyroid surgery. Arch Otolaryngol Head Neck Surg 1996;122:369-74.
4. Norman J, Cheda H. Minimally invasive radioguided parathyroidectomy facilitated by intraoperative nuclear mapping. Surgery 1997;122:998-1004.
5. Rubello D, Pelizzo MR, Casara D. Nuclear medicine and minimally invasive surgery of parathyroid adenomas: a fair marriage [editorial]. Eur J Nucl Med Mol Imaging 2003;30:189-92.
6. Sackett WR, Barraclough B, Reeve TS, Delbridge LW. Worldwide trends in the surgical treatment of primary hyperparathyroidism in the era of minimally invasive parathyroidectomy. Arch Surg 2002;137:1055-9.
7. Irvin GL 3rd. American Association of Endocrine Surgeons. Presidential address: chasin' hormones. Surgery 1999;126:993-7.
8. Irvin GL 3rd, Carneiro DM. Rapid parathyroid hormone assay guided exploration. Operative Techniques Gen Surg 1999;1:18-27.
9. Lloyd MN, Lees WR, Milroy EJ. Pre-operative localisation in primary hyperparathyroidism. Clin Radiol 1990; 41:239-43.
10. Ahuja AT, Wong KT, Ching AS, Fung MK, Lau JYW, Yuen EHY, et al. Imaging for primary hyperparathyroidism-what beginners should know. Clin Radiol 2004;59:967-76.
11. Miller DL, Doppman JL, Krudy AG, Shawker TH, Norton JA, Vucich JJ, et al. Localisation of parathyroid adenomas in patients who have undergone surgery. Radiology 1987;162:133-7.
12. 99mTc-sestamibi gamma probe technique in planning unilateral and minimally invasive surgery in primary hyperparathyroidism. Eur J Nucl Med 2001;28:1351-9.
13. Uden P, Aspelin P, Berglund J. Preoperative localization in unilateral parathyroid surgery. A cost-benefit study on ultrasound, computed tomography and scintigraphy. Acta Chir Scand 1990;156:29-35.
14. 99mTc-MIBI scintigraphy and US for demonstration of parathyroid glands and nodules. Radiology 2000;214:393-402.
15. 4/MIBI scan, ultrasound and intra-operative gamma probe in the performance of unilateral and minimally invasive surgery in primary hyperparathyroidism. Eur J Nucl Med 2001;28:1351-9.
16. Eisenberg H, Pallotta J, Sacks B, Brickman AS. Parathyroid localisation, three dimensional modelling and percutaneous ablation techniques. Endocrin Metab Clinics North Am 1989;18:659-700.
17. Mitchell BK, Merrell RC, Kinder BK. Localization studies in patients with hyperparathyroidism. Surg Clin North Am 1995;75:483-98.
18. Koong HN, Choong LH, Soo KC. The role of preoperative localisation techniques in surgery for hyperparathyroidism. Ann Acad Med Singapore 1998;27:192-5.
19. Weber AL, Randolph G, Aksoy FG. The thyroid and parathyroid glands. CT and MR imaging and correlation with pathology and clinical findings. Radiol Clin North Am 2000;38:1105-29.
20. Lee VS, Spritzer CE. MR imaging of abnormal parathyroid glands. Am J Roentgenol 1998;170:1097-103.
21. Hishibashi M, Nishida H, Hiromatsu Y, Kojima K, Tabuchi E, Hayabuchi N. Comparison of technetium-99m-MIBI, technetium-99m-tetrofosmin, ultrasound, and MRI for localization of abnormal parathyroid glands. J Nucl Med 1988;39:320-4.
22. Fayet P, Hoeffel C, Fulla Y, Legmann P, Hazebroucq V, Luton JP, et al. Techetium-99m-sestamibi, magnetic resonance imaging and venous blood sampling in persistent and recurrent hyperparathyroidism. Br J Radiol 1997;70:459-64.
23. 99mTc-MIBI scintigraphy in the evaluation of recurrent or persistent hyperparathyroidism. Radiology 2001;218:783-90.
24. Seehofer D, Steinmuller T, Rayes N, Podrabsky P, Riethmuller J, Klupp J, et al. Parathyroid hormone venous sampling before reoperative surgery in renal hyperparathyroidism: comparison with noninvasive localization procedures and review of the literature. Arch Surg 2004;139:1331-8.
25. 75Se]Selenomethionine scanning for parathyroid localization should be abandoned. Mayo Clin Proc 1984;59:534-7.
26. Samanta A, Wilson B, Iqbal J, Burden AC, Walls J, Cosgriff P. A clinical audit of thallium-technetium subtraction parathyroid scans. Postgrad Med J 1990;66:441-5.
27. 99mTc-sestamibi-a new agent for parathyroid imaging. Nucl Med Commun 1989;10:791-4.
28. Hetrakul N, Civelek AC, Stag CA, Udelsman R. In vitro accumulation of technetium-99m sestamibi in human parathyroid mitochondria. Surgery 2001;130:1011-8.
29. Bhatnagar A, Vezza PR, Bryan JA, Atkins FB, Ziessman HA. Technetium-99m-sestamibi parathyroid scintigraphy: effect of P-glycoprotein, histology and tumor size on detectability. J Nucl Med 1998;39:1617-20.
30. Chudzinski W, Niderla J, Lasiecka Z, Wilczynski G, Gornicka B, Wasiutynshi A, et al. P-glycoprotein expression influences the result of 99mTc-MIBI scintigraphy in tertiary hyperparathyroidism. Int J Mol Med 2005;16:215-9.
31. Grzela T, Chudzinski W, Lazarczyk M, Niderla J, Dziunycz P, Milewski L, et al. Persisted/recurrent hyperparathyroidism associated with development of multi-drug resistance phenotype and proliferation of parathyroid transplants. Int J Mol Med 2004;14:559-99.
32. Grzela T, Chudzinski W, Lasiecka Z, Niderla J, Wilczynski G, Gornicka B, et al. The calcium-sensing receptor and vitamin D receptor expression in tertiary hyperparathyroidism. Int J Mol Med 2006;17:779-83.
33. Taillefer R, Boucher Y, Potvin C, Lambert R. Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99m-sestamibi (double phase study). J Nucl Med 1992;33:1801-7.
34. 99mTc-MIBI and ultrasound imaging protocol. Eur J Nucl Med 2000;27:1300-4.
35. Perrier ND, Ituarte PHG, Morita E, Hamill T, Gielow R, Duh QY, et al. Parathyroid surgery: separating promise from reality. J Clin Endocrinol Metab 2002;87:1024-8, discussion 1028-9.
36. Bénard F, Lefebvre B, Beuvon F, Langlois MF, Bisson G. Rapid wash-out of technetium-99m-MIBI from a large parathyroid adenoma. J Nucl Med 1995;36:241-3.
37. Geatti O, Shapiro B, Orsolon P, Proto G, Guerra UP, Antonucci F, et al. Localization of parathyroid enlargement: experience with technetium 99m methoxyisobutylisonitrile and thallium-201 scintigraphy, ultrasound and computed tomography. Eur J Nucl Med 1994;21:17-23.
38. Rubello D, Saladini G, Casara D, Borsato N, Toniato A, Piotto A, et al. Parathyroid imaging with pertechnetate plus perchlorate/MIBI subtraction scintigraphy. A fast and effective technique. Clin Nucl Med 2000;25:527-31.
39. Sfakianakis GN, Irvin GL III, Foss J, Mallin W, Georgiou M, Deriso GT, et al. Efficient parathyroidectomy guided by SPECT-MIBI and hormonal measurements. J Nucl Med 1996;37:798-804.
40. Hindie E, Melliere D, Jeanguillame C, Perlemuter L, Chehade F, Galle P. Parathyroid imaging using simultaneous double window recording of technetium-99m-sestamibi and iodine-123. J Nucl Med 1998;39:1100-5.
41. Moka D, Eschner W, Voth E, Dietlein M, Larena-Avellaneda A, Schicha H. Iterative reconstruction: an improvement of technetium-99m-MIBI SPECT for the detection of parathyroid adenoma? Eur J Nucl Med 2000;27:485-9.
42. 99mTc-MIBI dose: technical considerations and long-term clinical results. Q J Nucl Med 2003;47:224-32.
43. Billotey C, Sarfati E, Aurengo A, Duet M, Mundler O, Toubert ME, et al. Advantages of SPECT in technetium-99m-sestamibi parathyroid scintigraphy. J Nucl Med 1996;37:1773-8.
44. 99mTc sestamibi scanning and intraoperative quick parathormone assay. Surgery 1997;122:1107-16.
45. Gallowitsch JH, Mikosch P, Kresnik E, Gomez I, Lind P. Technetium-99m-tetrofosmin parathyroid imaging: results with double-phase study and SPECT in primary and secondary hyperparathyroidism. Invest Radiol 1997;32:459-65.
46. 99mTc-sestamibi subtraction SPECT in hyperparathyroidism. Am J Roentgenol 1997;169:1671-4.
47. Francis IS, Loney EL, Buscombe JR, Thakrar DS, Berger L, Hilson AJW. Technetium-99m-sestamibi dual-phase SPECT imaging: concordance with ultrasound. Nucl Med Commun 1999;20:487-8.
48. O'Doherty MJ, Kettle AG, Wells P, Collins REC, Coakley AJ. Parathyroid imaging with technetium-99m-sestamibi: preoperative localization and tissue uptake studies. J Nucl Med 1992;33:313-8.
49. Spanu A, Falchi A, Manca A, Marongiu P, Cossu A, Pisu N, et al. The usefulness of neck pinhole SPECT as a complementary tool to planar scintigraphy in primary and secondary hyperparathyroidism. J Nucl Med 2004;45:40-8.
50. 99mTc-sestamibi SPECT/CT over conventional SPECT in the evaluation of parathyroid adenomas or hyperplasia. J Nucl Med 2005;46:248-52.
51. Denham DW, Norman J. Cost-effectiveness of preoperative sestamibi scan for primary hyperparathyroidism is dependent solely upon the surgeons choice of operative procedure. J Am Coll Surg 1998;186:293-304.
52. George EF, Komisar A, Scharf SC, Ferracci A, Blaugrund S. Diagnostic value of the preoperative sestamibi scan in intraoperative localisation of parathyroid adenomas: a case study. Laryngoscope 1998;108:627-9.
53. Chen H, Sokoll LJ, Udelsman R. Outpatient minimally invasive parathyroidectomy: a combination of sestamibi-SPECT localisation, cervical block anaesthesia, and intraoperative parathyroid hormone assay. Surgery 1999;126:1016-21.
54. Kumar A, Cozens NJA, Nash JR. Sestamibi scan-directed unilateral neck exploration for primary hyperparathyroidism due to a solitary adenoma. Eur J Surg Oncol 2000;26:785-8.
55. 99mTc-sestamibi for double-phase parathyroid scintigraphy? Eur J Nucl Med Mol Imaging 2003;30:193-6.
56. 99mTc-tetrofosmin SPECT for preoperative localization of parathyroid adenoma in an endemic goiter area. Invest Radiol 2000;35:453-9.
57. Neumann DR, Esselstyn CB, MacIntyre WJ, Go RT, Obuchowski NA, Chen EQ, et al. Comparison of FDG-PET and sestamibi SPECT in primary hyperparathyroidism. J Nucl Med 1996;37:1809-15.
58. Melon P, Luxen A, Hamoir E, Meurisse M. Fluorine-18-fluorodeoxyglucose positron emission tomography for preoperative parathyroid imaging in primary hyperparathyroidism. Eur J Nucl Med 1995;22:556-8.
59. Sundin A, Johansson C, Hellman P, Bergstrom M, Ahlstrom H, Jacobson GB, et al. PET and parathyroid L-[carbon-11]methionine accumulation in hyperparathyroidism. J Nucl Med 1996;37:1766-70.
60. 11C-methionine positron emission tomography. Nucl Med Commun 2005:26:133-6.
61. Norman JG. Minimally invasive radioguided parathyroidectomy: an endocrine surgeon's perspective. J Nucl Med 1998;39:15N-24N.
62. 99mTc-MIBI radio-guided minimally invasive parathyroidectomy: experience with patients with normal thyroids and nodular goiters. Thyroid 2002;12:53-61.
63. Rubello D, Casara D, Pelizzo MR. Symposium on parathyroid localization. Optimization of peroperative procedures. Nucl Med Commun 2003;24:133-40.
64. Flynn MB, Bumpous JM, Schill K, McMasters KM. Minimally invasive radioguided parathyroidectomy. J Am Coll Surg 2000;191:24-31.
65. Goldstein RE, Blevins L, Delbeke D, Martin WH. Effect of minimally invasive radioguided parathyroidectomy on efficacy, length of stay, and costs in the management of primary hyperparathyroidism. Ann Surg 2000;231:732-42.
66. Koong HN, Choong LH, Soo KC. The role of preoperative localisation techniques in surgery for hyperparathyroidism. Ann Acad Med Singapore 1998;27:192-5.
67. Norman J, Denham D. Minimally invasive radioguided parathyroidectomy in the reoperative neck. Surgery 1998;124:1088-93.
68. Bonjer HJ, Bruining HA, Pols HAP, de Herder WW, van Eijck CH, Breeman WA, et al. Intraoperative nuclear guidance in benign hyperparathyroidism and parathyroid cancer. Eur J Nucl Med 1997;24:246-51.
69. Chapius Y, Fulla Y, Bonnichon P, Tarla E, Abbound B, Pitre J, et al. Values of ultrasonography, sestamibi scintigraphy and intraoperative measurement of 1-84 PTH for unilateral neck exploration of primary hyperparathyroidism. World J Surg 1996;20:835-40.
70. Giordano A, Rubello D, Casara D. New trends in parathyroid scintigraphy. Eur J Nucl Med 2001;28:1409-20.
71. Rubello D, Casara D, Shapiro B. Recent advances in preoperative and intraoperative nuclear medicine procedures in patients with primary hyperparathyroidism. Panminerva Med 2002;44:99-105.